AUS
NZ
UK
CA
USA
IND
Healthcare
Recce Pharmaceuticals Reports Patent For Its Antibiotics
March 15, 2019 07:09 PM AEDT| By Team Kalkine MediaRecce Pharmaceuticals Limited (ASX: RCE) is first in developing and commercialisation of a new class of synthetic antibiotics. It has a broad range of activity designed to address the urgent global health problem of antibiotic-resistant superbugs. It...
Why BARD1 Life Sciences Looks Lucrative To Investors?
March 15, 2019 06:42 PM AEDT| By Team Kalkine MediaBiotechnology pioneer, BARD1 Life Sciences Limited (ASX: BD1) has the potential to diagnose lung and ovarian cancers at an early stage. The company, committed to transforming the early detection and prevention of cancer, has built a proprietary techn...
dorsaVi Ltd Announces Operational Changes To Reduce Its Expenses And Optimize Cash Reserve
March 15, 2019 03:27 PM AEDT| By Team Kalkine MediaMedical technology company, dorsaVi Ltd (ASX: DVL) is planning to make some operational changes to reduce its operating costs, build revenue and sales capability, and optimize cash reserves. In an announcement made on 15 March 2019, the company has...
1st Group Limited Inked Strategic Pilot Agreement With Medibank
March 15, 2019 03:09 PM AEDT| By Team Kalkine Media1st Group Limited (ASX: 1ST) is into digital health group, building the leading health services portal of Australia, MyHealth1st.com.auâ, Australiaâs online pet service portal âPetYeti.com.auâ and corporate and...
Pharmaust Limited’s Shares Jumped Over 9.3% On ASX After Announcement Of Positive Results From Phase 1 Trial
March 14, 2019 10:43 PM AEDT| By Team Kalkine MediaPharmaust Limited (ASX: PAA) is into its clinical-stage. The company is into developing targeted cancer therapeutics for human as well as animals. It is specialised in using its marketed drugs for a different purpose, which lowers the risks and costs...
OptiScanReleases Investor Presentation: Stock Surged Over 2%
March 14, 2019 09:57 PM AEDT| By Team Kalkine MediaOptiScan Imaging Limited (ASX: OIL) is into the research and development of a High Magnification Endoscope for clinical diagnosis and research; and the continuation of sales of the research grade benchtop confocal microscope system within Australia....
Australian Pharmaceutical Releases Market Update on API-Sigma Merger Proposal
March 14, 2019 07:37 PM AEDT| By Team Kalkine MediaAustralian Pharmaceutical Industries Limited (ASX: API) has acknowledged the announcement made by Sigma Healthcare rejecting merger proposal on a non-binding indicative offer made by API. The offer was valued at a premium of 41.8% over the undisturbe...
Phylogica Limited Announces A Collaboration Agreement With Ramot
March 14, 2019 05:13 PM AEDT| By Team Kalkine MediaPhylogica Limited (ASX: PYC) is a biopharmaceutical company that utilises proprietary drug discovery technologies to discover and develop novel peptide therapeutics. The company, today on 14 March 2019, announced that it has entered into a Research...
Imugene Reports Dosing Of First Patient In The HER-Vaxx Cancer Vaccine Phase 2 Study: Shares Rose Over 5%
March 14, 2019 03:33 PM AEDT| By Team Kalkine MediaImugene Limited (ASX: IMU) is into the operations of immuno-oncology. It is in its clinical stage and is into the development of a range of new and novel immunotherapies which helps to activate the immune system of cancer patients to treat and eradic...
HomeStay commenced live trial of MyDay and Carers Companion app with St John of God Health Care
March 14, 2019 02:56 PM AEDT| By Team Kalkine MediaHomeStay Care Limited (ASX: HSC) is in a unique business of designing and developing a scalable healthcare technology platform called the HomeStay Internet of Things (IoT) Platform which is intended to protect and take care of elderly people. The tec...
Medlab Clinical announced strong outcomes from the clinical trials and government approved SAS’s use of NanaBis drug
March 14, 2019 12:28 AM AEDT| By Team Kalkine MediaMedlab Clinical Limited (ASX: MDC) is a medical research and development company based in Australia. It is researching and formulating novel bio-therapeutic drugs for treatment of early to moderate stage chronic diseases. According to the National C...
ResApp Health Received Green Light from AusIndustry for R&D Advanced Overseas Finding
March 13, 2019 08:44 PM AEDT| By Team Kalkine MediaThe developer of digital healthcare solutions, ResApp Health Limited (ASX: RAP) has notified the market that it had obtained approval from AusIndustry regarding its application, for an Advanced/Overseas Finding in connection with clinical study expen...
Paradigm Biopharmaceuticals published Investor Presentation: Stock surged over 9%
March 13, 2019 04:04 PM AEDT| By Team Kalkine MediaASX listed, a biotechnology company, Paradigm Biopharmaceuticals Limited (ASX: PAR) has published its investor presentation. PAR is engaged in developing ethically safe drug for the treatment of musculoskeletal disorders in human. The company is cur...
Sigma Healthcare Provides An Update On API Proposal
March 13, 2019 02:15 PM AEDT| By Team Kalkine MediaThe Board of Sigma Healthcare Limited (ASX: SIG) believes that the current API proposal is not reflecting the long-term prospects and value inherent in Sigma, which is why the Board has concluded that the current API proposal is not in the best inter...
Ellex Medical’s Shares Uplifted On ASX After Announcing The Results Of Its LiGHT’s Clinical Trial
March 12, 2019 06:47 PM AEDT| By Team Kalkine MediaLeading medical technology company, Ellex Medical Lasers Limited (ASX: ELX) have announced the results of Laser in Glaucoma and Ocular HyperTension (LiGHT) clinical trial which demonstrated that selective laser trabeculoplasty (SLT) is safe and effec...
Cynata to go Ahead with their Phase 2 Clinical Trial Post Favourable Advice from MHRA
March 12, 2019 04:58 PM AEDT| By Team Kalkine MediaCynata Therapeutics (ASX: CYP) is an Australian biotechnology company which is in the business of researching and manufacturing regenerative medicine targeted towards the development of therapies based on a proprietary therapeutic stem cell platform...
Zelda Therapeutics Enters Binding Agreement With Ilera For Deriving Advantage in Commercialisation
March 12, 2019 04:29 PM AEDT| By Team Kalkine MediaZelda Therapeutics Limited (ASX: ZLD) is a cannabis group which works on a varied range of formulations based on cannabinoid for treating several medical conditions. It specializes in the development of medicines which are used for the treatment of t...
Opthea Limited Announces the Addition of OPT ticker in All Ordinaries, Effective from March 18, 2019
March 12, 2019 02:59 PM AEDT| By Team Kalkine MediaOpthea Limited (ASX: OPT) is into biotechnology. The company is into the development of a novel biologic therapy, OPT-302, which is used for the treatment of eye diseases, by blocking two members of the vascular endothelial growth factor family VEGF-...
Starpharma strengthens its cash positions on the receipt of $4.0 million tax refund
March 12, 2019 02:42 PM AEDT| By Team Kalkine MediaStarpharma Holdings Limited (ASX: SPL) announced that the company has received the Research & Development Tax Incentive refund of $4.0 million from the Australian Government. The refund relates to the costs of Research and Development activities...
Althea Group Announced Investor Update And Board Changes
March 11, 2019 05:03 PM AEDT| By Team Kalkine MediaAn Australian owned licensed importer and producer of medical cannabis, Althea Group Holdings Ltd (ASX: AGH) has published a presentation for the investors on 7 March 2019. The presentation contains an update about AGH?s operations and product range,...
Advertise your brand on Kalkine Media